Showing results (111-120 of 264) with videos related to
Sort By:
Pageof 27
Archives of General Psychiatry|February 8, 2006
Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depressionMichael A Rapp, Michal Schnaider-Beeri, Hillel T Grossman, et al.British Journal of Anaesthesia|June 16, 2020
Human plasma biomarker responses to inhalational general anaesthesia without surgeryStacie Deiner, Mark G Baxter, Joshua S Mincer, et al.Alzheimer Disease and Associated Disorders|December 14, 2004
Reliability of monitoring the clinical dementia rating in multicenter clinical trialsKimberly A Schafer, Rochelle E Tractenberg, Mary Sano, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthRachel R Litke, Arushi Arora, Yihan Wang, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Measuring informed consent capacity in an Alzheimer's disease clinical trialPeter D Guarino, Julia E Vertrees, Sanjay Asthana, et al.Neurobiology of Aging|April 13, 2010
Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer diseaseGuiqing Cai, Gil Atzmon, Adam C Naj, et al.Alzheimer Disease and Associated Disorders|July 2, 2010
Pilot study to show the feasibility of a multicenter trial of home-based assessment of people over 75 years oldMary Sano, Susan Egelko, Steven Ferris, et al.Proceedings of the National Academy of Sciences of the United States of America|September 16, 2015
Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesisLi Zhu, Minghao Zhong, Gregory A Elder, et al.Molecular Psychiatry|April 15, 2025
Neocortical tau propagation is a mediator of clinical heterogeneity in Alzheimer's diseaseAnjalika Chongtham, Aarthi Ramakrishnan, Marissa Farinas, et al.Neuropsychology|July 24, 2013
Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderlyDavid P Salmon, Steven H Ferris, Ronald G Thomas, et al.Pageof 27